When there is a pandemic there is no time to waste: should we have hydroxychloroquine in our armoury against COVID-19 infected patients?
The current use of chloroquine and/or hydroxychloroquine, a drug currently used to treat autoimmune rheumatic diseases, in treating severe acute respiratory syndrome caused by coronavirus 2 (SARSCoV-2) or COVID-19-infected patients with pneumonia is a matter of intense consideration. We wish to ente...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PCO Convin S.A.
2019-01-01
|
| Series: | Mediterranean Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.mjrheum.org/assets/files/792/file219_1107.pdf |